Staphylococcus aureus:: Staphylokinase

被引:115
作者
Bokarewa, MI [1 ]
Jin, T [1 ]
Tarkowski, A [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Rheumatol & Inflammat Res, SE-41346 Gothenburg, Sweden
关键词
infection; Staphylococci; staphylokinase; defensins; plasminogen;
D O I
10.1016/j.biocel.2005.07.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staphylokinase is a 136 aa long bacteriophage encoded protein expressed by lysogenic strains of Staphylococcus aurelts. Present understanding of the role of staphylokinase during bacterial infection is based on its interaction with the host proteins, alpha-defensins and plasminogen. alpha-Defensins are bactericidal peptides originating from human neutrophils. Binding of staphylokinase to alpha-defensins abolishes their bactericidal properties, which makes staphylokinase a vital tool for staphylococcal resistance to host innate immunity. Complex binding between staphylokinase and plasminogen results in the formation of active plasmin, a broad-spectrum proteolytic enzyme facilitating bacterial penetration into the surrounding tissues. We have recently shown high levels of staphylokinase expression in clinical isolates of skin and mucosal origin and relative low levels in isolates invading internal organs. These findings are supported by sepsis studies using isogenic S. aureus strains demonstrating increased bacterial load in the absence of staphylokinase production. Our observations indicate that staphylokinase favours symbiosis of staphylococci with the host that makes it an important colonization factor. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:504 / 509
页数:6
相关论文
共 28 条
[11]   Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism [J].
Jin, T ;
Bokarewa, M ;
Foster, T ;
Mitchell, J ;
Higgins, J ;
Tarkowski, A .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :1169-1176
[12]   Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains [J].
Jin, T ;
Bokarewa, M ;
McIntyre, L ;
Tarkowski, A ;
Corey, GR ;
Reller, LB ;
Fowler, VG .
JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (10) :919-923
[13]  
JIN T, 2005, UNPUB ROLE STAPHYLOK
[14]   A novel variant of staphylokinase gene from Staphylococcus aureus ATCC 29213 [J].
Kim, SH ;
Chun, HS ;
Han, MH ;
Park, NY ;
Suk, K .
THROMBOSIS RESEARCH, 1997, 87 (04) :387-395
[15]   Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes [J].
Laroche, Y ;
Heymans, S ;
Capaert, S ;
De Cock, F ;
Demarsin, E ;
Collen, D .
BLOOD, 2000, 96 (04) :1425-1432
[16]  
Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226
[17]   Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α-enolase [J].
López-Alemany, R ;
Longstaff, C ;
Hawley, S ;
Mirshahi, M ;
Fábregas, P ;
Jardí, M ;
Merton, E ;
Miles, LA ;
Félez, J .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (04) :234-242
[18]   Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase [J].
Mölkänen, T ;
Tyynelä, J ;
Helin, J ;
Kalkkinen, N ;
Kuusela, P .
FEBS LETTERS, 2002, 517 (1-3) :72-78
[19]  
Novick RP, 2000, GRAM-POSITIVE PATHOGENS, P392
[20]   Nuclear magnetic resonance solution structure of the plasminogen-activator protein staphylokinase [J].
Ohlenschläger, O ;
Ramachandran, R ;
Gührs, KH ;
Schlott, B ;
Brown, LR .
BIOCHEMISTRY, 1998, 37 (30) :10635-10642